JYLAMVO

This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug JYLAMVO contains one active pharmaceutical ingredient (API):

1 Methotrexate
UNII YL5FZ2Y5U1 - METHOTREXATE

Methotrexate (4-amino-10-methylfolic acid) is a folic acid antagonist which inhibits the reduction of folic acid and increase of tissue cells. Methotrexate enters the cell through an active transport mechanism of reduced folates. As a result of polyglutamation of methotrexate caused by the folylpolyglutamylate enzyme, the duration of the cytotoxic effect of the drug substance in the cell increases.

Read about Methotrexate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
JYLAMVO Oral solution European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01BA01 Methotrexate L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BA Folic acid analogues
Discover more medicines within L01BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1742587
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 185130
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 348711
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1082615
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100386812
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65904001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.